These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4361177)

  • 1. Heterogeneity of virus production and antigenicity detected in cell clones derived from a "nonproducer" neoplasm induced by Moloney murine sarcoma virus.
    Law LW; Chang KS; Nakata K
    J Natl Cancer Inst; 1974 Feb; 52(2):437-43. PubMed ID: 4361177
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenic properties of a nonproducer malignant tumor induced by murine sarcoma virus.
    Law LW; Chang KS; Ting RC
    Proc Soc Exp Biol Med; 1976 Sep; 152(4):585-8. PubMed ID: 967890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

  • 4. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF
    Int J Cancer; 1973 Sep; 12(2):378-88. PubMed ID: 4134124
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.
    Law LW; Ting RC
    J Natl Cancer Inst; 1970 Mar; 44(3):615-21. PubMed ID: 11515430
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.
    Aoki T; Stephenson JR; Aaronson SA
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):742-6. PubMed ID: 4351802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells.
    Stephenson JR; Aaronson SA
    J Exp Med; 1972 Mar; 135(3):503-15. PubMed ID: 4550769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice.
    McCoy JL; Dean JH; Law LW; Williams J; McCoy NT; Holiman BJ
    Int J Cancer; 1974 Aug; 14(2):264-76. PubMed ID: 4142466
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.
    Jasmin C; Chermann JC; Herve G; Teze A; Souchay P; Boy-Loustau C; Raybaud N; Sinoussi F; Raynaud M
    J Natl Cancer Inst; 1974 Aug; 53(2):469-74. PubMed ID: 4367244
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
    Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
    J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.
    Weiland E; Mussgay M; Weiland F
    J Exp Med; 1978 Aug; 148(2):408-23. PubMed ID: 151722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.